Back to top of page

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)

1. Name of the applicant/organization

2. Contact information (address, phone number, email)

3. Project title

4. Description of the proposed therapeutic agent(s)

5. Description of the neurological or neuromuscular disorder being targeted

6. Statement describing how the proposed therapeutic agent(s) align with the NINDS mission

7. Pharmacodynamic data demonstrating the biological activity of the therapeutic agent(s)

8. Pharmacokinetic data supporting the potential efficacy and safety of the therapeutic agent(s)

9. In vivo efficacy data showing the potential effectiveness of the therapeutic agent(s)

10. Justification for further development of the therapeutic agent(s)

11. Plan for meeting the entry criteria of the Blueprint Neurotherapeutics Network or other translational programs

12. Budget proposal including requested funding amount and breakdown of expenses

13. Timeline for project execution and completion

14. Previous research or development efforts related to the proposed therapeutic agent(s)

15. Relevant publications or patents related to the therapeutic agent(s)

16. Any collaborations or partnerships involved in the project

17. Potential risks or challenges associated with the project

18. Anticipated outcomes and potential impact of the project on neurological or neuromuscular disorder treatment.

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows